Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CMS Fields Comments On Who Should Have Bariatric Surgery For Diabetes

This article was originally published in The Gray Sheet

  • News

Executive Summary

Endocrinologists are cautioning CMS against making any immediate policy changes on how Medicare covers bariatric surgery to treat diabetes

You may also be interested in...



CMS Proposes Coverage Of Surgery For Diabetes Only In Morbidly Obese

Type-2 diabetics who are not classified as "morbidly obese" would not receive Medicare coverage for bariatric surgery under a Nov. 17 CMS 1proposal

CMS Proposes Coverage Of Surgery For Diabetes Only In Morbidly Obese

Type-2 diabetics who are not classified as "morbidly obese" would not receive Medicare coverage for bariatric surgery under a Nov. 17 CMS 1proposal

Covidien Aims To Breathe Life Into Respiratory Biz With Ventilation Pipeline

Covidien plans to reinvigorate its respiratory business by targeting higher-growth market segments, such as devices to combat ventilator-associated pneumonia, the company said during its Sept. 10 investor day in New York

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight
Tags:
Latest Headlines

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application

See All
UsernamePublicRestriction

Register

MT026239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By